Benjamin L Palleiko sold $517K of KalVista Pharmaceuticals (KALV)

Executed Jul 9 2025, disclosed Jul 10 2025, 1 day later.

Value, as filed

$517K

32,979 sh × $15.69

Executed

Jul 9 2025

the trade date, as filed

Disclosed

Jul 10 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

BP Benjamin L Palleiko CHIEF EXECUTIVE OFFICER profile →

Benjamin L Palleiko (CHIEF EXECUTIVE OFFICER) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in KALV. The largest single filing was $293K of KALV (10,926 sh × $26.78, as filed), executed May 22.

The name

KALV KALV KALV · 19 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Benjamin L Palleiko in KALV

KALVSALE KalVista Pharmaceuticals, Inc. $293K
10,926 sh × $26.78
Exec May 22
Filed May 26 · 5:30 PM ET KALVSALE KalVista Pharmaceuticals, Inc. $193K
9,550 sh × $20.22
Exec Apr 17
Filed Apr 20 · 5:30 PM ET KALVSALE KalVista Pharmaceuticals, Inc. $108K
6,693 sh × $16.08
Exec Mar 9
Filed Mar 10 · 5:30 PM ET KALVSALE KalVista Pharmaceuticals, Inc. $156K
10,034 sh × $15.57
Exec Feb 23
Filed Feb 24 · 5:30 PM ET KALVSALE KalVista Pharmaceuticals, Inc. $120K
7,294 sh × $16.51
Exec Dec 8 2025
Filed Dec 9 2025 · 5:30 PM ET KALVSALE KalVista Pharmaceuticals, Inc. $147K
10,940 sh × $13.45
Exec Nov 24 2025
Filed Nov 26 2025 · 5:30 PM ET KALVSALE KalVista Pharmaceuticals, Inc. $116K
7,294 sh × $15.84
Exec Sep 8 2025
Filed Sep 9 2025 · 5:30 PM ET KALVSALE KalVista Pharmaceuticals, Inc. $145K
10,940 sh × $13.22
Exec Aug 22 2025
Filed Aug 25 2025 · 5:30 PM ET